Skip to main content
. 2020 Sep;8(17):1048. doi: 10.21037/atm-20-4363

Table 3. Adverse reactions and cytokine of levels after treatment.

Patient No. Highest temperature (°C) Fever duration (d) Maximum copy amount (×105) Peak amplification time (d) No. of CAR positive T Cells Infused (×106/kg) Toxicities
CRS (grade and feature) CRES (grade and feature)
P007 39.8 6 1.200 7 1.8 2 (fever, hypotension, vomiting chills) 3 (convulsion, confusion)
P011 39.5 6 1.805 7 2.0 1 (fever, sore muscles) 0
P014 38.9 7 0.750 11 1.0 2 (fever, chilsl, emesis) 0
P016 38.5 6 2.950 7 2.0 2 (fever, weak, loss of appetite) 2 (dysphoria, delirium)
P018 39.9 3 1.200 7 2.0 1 (fever) 1 (confusion, delays in response)
P025 39.8 8 1.014 11 2.0 1 (fever) 0
P032 39.0 7 0.077 7 2.0 1 (fever) 0
P040 39.0 9 0.131 10 3.0 2 (fever, lung infection) 0
P108 38.3 6 0.783 7 2.0 1 (fever) 0
P185 37.1 0 0.127 10 3.0 0 0
P189 37.9 3 0.935 10 3.0 1 (fever) 0

CAR, chimeric antigen receptor; CRS, cytokine release syndrome; CRES, CART-cell-related encephalopathy syndrome.